OPEN END TURBO CALL WARRANT - FRESENIUS MEDICAL CARE Share Price

Certificat

DE000UK66TB1

Delayed Deutsche Boerse AG 07:04:22 26/06/2024 pm IST
0.84 EUR -3.45% Intraday chart for OPEN END TURBO CALL WARRANT - FRESENIUS MEDICAL CARE
Current month-28.69%
1 month-28.10%
Date Price Change
26/24/26 0.84 -3.45%
25/24/25 0.87 -5.43%
24/24/24 0.92 +10.84%
21/24/21 0.83 -11.70%
20/24/20 0.94 +3.30%

Delayed Quote Deutsche Boerse AG

Last update June 26, 2024 at 07:04 pm IST

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellCALL
Underlying FRESENIUS MEDICAL CARE AG
Issuer UBS
WKN UK66TB
ISINDE000UK66TB1
Date issued 23/09/2022
Strike 27.25
Maturity Unlimited
Parity 10 : 1
Emission price 0.52
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 2.36
Lowest since issue 0.075
Spread 0.01
Spread %1.18%

Company Profile

Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.
Sector
-
More about the company

Ratings for Fresenius Medical Care AG

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius Medical Care AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
35.67 EUR
Average target price
39.97 EUR
Spread / Average Target
+12.07%
Consensus